HOME >> BIOLOGY >> NEWS
Microarray technology for tailoring breast cancer therapy

Microarray technology could be used to tailor therapy according to the individual, and prevent breast cancer patients from having to undergo painful unsuccessful therapies. In a study published in the journal Breast Cancer Research, researchers analysed tumour tissue samples and identified a group of 64 genes that can be used to predict a patient's response in the five years after adjuvant therapy for breast cancer. Identifying patients whose breast tumours express these genes could potentially be used to predict which patients would not benefit from adjuvant therapy, and avoid patients being given therapies with the potential of causing more harm than good.

A team of researchers led by Jonas Bergh from the Karolinska Institutet in Stockholm, Sweden, analysed the gene expression profiles of 159 breast cancer patients using DNA microarray analysis. From these samples they identified the genetic signatures shown by 38 patients who had a poor prognosis - defined as relapse or death from any cause within 5 years. The remaining 121 patients were defined as the 'good prognosis' group. The researchers also used gene expression profiling to separate patients who did well with and without adjuvant therapy, and those whose tumours failed to respond to treatment.

An analysis of the genes expressed in the tumours of all 159 patients showed that 64 genes were used to separate the patients with good and poor prognoses. The researchers then tested the predictive value of the group of 64 genes compared with three currently used clinical markers. Using the expression patterns of the 64 genes identified by the researchers gave significantly better (P=0.007) prediction rates than histological grading, tumour stage and age - which are all accepted prognostic markers for breast cancer.

The present lack of criteria to help tailor breast cancer treatment to individual patients indicates a need to develop new techniques for better prediction of how patients wi
'"/>

Contact: Prof Per Hall
per.hall@ki.se
46-73-625-0342
Karolinska Institutet
2-Oct-2005


Page: 1 2

Related biology news :

1. The Center of Nutrigenomics of the TU Munich licences Genomatix Microarray Analysis Pipeline
2. German Microarray Excellence Center integrates Genomatix Chip Analysis Pipeline
3. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible status
4. Microarrays as phenotype
5. AFCYBER holds science and technology symposium
6. New technology reveals seal behavior
7. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
8. FDA Nanotechnology Task Force takes positive step forward
9. Liverpool amongst first in UK to install unique DNA sequencing technology
10. EPA foregoes opportunity to improve nanotechnology oversight
11. The Cancer Genome Atlas awards funds for technology development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/29/2020)... ... January 29, 2020 , ... Jason ... and Data Sciences practice, providing consulting services for strategy, research and development and ... Mike Townley, co-founder and Managing Partner of CREO, an innovative management consulting and ...
(Date:1/28/2020)... (PRWEB) , ... January 28, 2020 , ... ... life sciences companies and government agencies, announced that the firm has established a ... country. Tunnell’s Cambridge office will be in the Cambridge Innovation Center (CIC), at ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cytonus Therapeutics Inc. today ... tech entrepreneur, and former senior management consultant at McKinsey & Company who holds ... alternative investment firm. , “Chris Thorne has exceptional business acumen with a ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... ... February 03, 2020 , ... ... MA, announce that OmniType, the 11-locus, single tube multiplex successor to Holotype HLA ... best-in-class product featuring locus-multiplexing and short library preparation, for HLA genotyping from sample ...
(Date:1/28/2020)... (PRWEB) , ... January 28, ... ... of enterprise software solutions for biopharmaceutical R&D, today announced the release of ... reinforces Genedata’s focus on supporting the implementation of Multi-Attribute Methods (MAM) for ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, the leader in “instant ... today announced the availability of neuroscience of transformational leadership workshops. These highly interactive, ... of leadership and change research to become great transformational leaders. The workshops ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive surgeons at ... New Jersey epitomize the notion that plastic surgery is much more than just cosmetic ... media. , Over the last 20 years NJ Top Docs, Dr. Andrew Elkwood, Dr. ...
Breaking Biology Technology:
Cached News: